Concepedia

Policy resistance to harm reduction for drug users and potential effect of change

Tim Rhodes, Amin Sarang, Peter Vickerman, Matthew Hickman

BMJ · 2010 · 45 citations · 9 references

DOI

Concepts

Abstract

Despite good evidence for its effectiveness in HIV prevention, countries such as Russia remain resistant to harm reduction. <b>Tim Rhodes and colleagues</b> show the obstacles to and potential benefits of changing policy on opiate substitution treatment

References

9

HIV and risk environment for injecting drug users: the past, present, and future

Steffanie A. Strathdee, Timothy B. Hallett, Natalia Bobrova et al. · The Lancet · 2010 · 562 citations

, , +13

Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users

Charlotte van den Berg, Colette Smit, Giel van Brussel et al. · Addiction · 2007 · 315 citations · Full text

, , +16

Preventing HIV infection among injecting drug users in high-risk countries: an assessment of the evidence

J. Frederic Dewhurst · AIDS Care · 2010 · 140 citations

, , +13

The impact of methadone or buprenorphine treatment and ongoing injection on highly active antiretroviral therapy (HAART) adherence: evidence from the MANIF2000 cohort study

Perrine Roux, Patrizia Carrieri, Virgine Villes et al. · Addiction · 2008 · 126 citations

, , +16

Model Projections on the Required Coverage of Syringe Distribution to Prevent HIV Epidemics Among Injecting Drug Users

Peter Vickerman, Matthew Hickman, Tim Rhodes et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2006 · 75 citations

, , +17